Loxo Oncology at Lilly (United States)
Efficacy of Larotrectinib inTRKFusion–Positive Cancers in Adults and Children
2018 · Alexander Drilon, Theodore W. Laetsch, et al. · New England Journal of Medicine
Efficacy of Selpercatinib in RET Fusion–Positive Non–Small-Cell Lung Cancer
2020 · Alexander Drilon, Geoffrey R. Oxnard, et al. · New England Journal of Medicine
Efficacy of Selpercatinib in RET-Altered Thyroid Cancers
2020 · Lori J. Wirth, Eric J. Sherman, et al. · New England Journal of Medicine